PANACEA BIOTEC
Back to Balance Sheet
|
PANACEA BIOTEC Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹309 Cr | ₹330 Cr | ₹774 Cr | ₹447 Cr | ₹622 Cr |
What is the latest Total Current Liabilities ratio of PANACEA BIOTEC ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹309 Cr |
Mar2023 | ₹330 Cr |
Mar2022 | ₹774 Cr |
Mar2021 | ₹447 Cr |
Mar2020 | ₹622 Cr |
How is Total Current Liabilities of PANACEA BIOTEC Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹309 Cr | -6.34 | |
Mar2023 | ₹330 Cr | -57.39 | |
Mar2022 | ₹774 Cr | 73.01 | |
Mar2021 | ₹447 Cr | -28.11 | |
Mar2020 | ₹622 Cr | - |
Compare Total Current Liabilities of peers of PANACEA BIOTEC
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PANACEA BIOTEC | ₹2,608.0 Cr | 5% | -1.2% | 52.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
CIPLA | ₹127,124.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics |
PANACEA BIOTEC Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PANACEA BIOTEC | 5% |
-1.2% |
52.9% |
SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses